_id
691842fe3c536f8df23176de
Ticker
WVE
Name
Wave Life Sciences Ltd
Exchange
NASDAQ
Address
Marina One East Tower, Singapore, Singapore, 018936
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://wavelifesciences.com
Description
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, an RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-N531, an exon skipping oligonucleotide for the treatment of Duchenne muscular dystrophy; and WVE-003, an allele-selective oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.
Last Close
16.75
Volume
2514200
Current Price
16.56
Change
-1.134328358208963
Last Updated
2025-12-05T13:59:16.112Z
Image
https://logo.clearbit.com/wavelifesciences.com
Ipo Date
2015-11-11T00:00:00.000Z
Market Cap
1273925248
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.6176555555555556
Sentiment Sources
9
Rating
4.6154
Target Price
19.8
Strong Buy
9
Buy
3
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
7608000
Cost Of Revenue
-
Gross Profit
7608000
Operating Expenses
63961000
Operating Income
-56353000
Interest Expense
-
Pretax Income
-53852000
Net Income
-53852000
Eps
-0.3210459894385575
Dividends Per Share
-
Shares Outstanding
167181784
Income Tax Expense
-
EBITDA
-51622000
Operating Margin
-740.7071503680337
Total Other Income Expense Net
2501000
Cash
196218000
Short Term Investments
-
Receivables
10000000
Inventories
-
Total Current Assets
215488000
Property Plant Equipment
22072000
Total Assets
241378000
Payables
14490000
Short Term Debt
8394000
Long Term Debt
-
Total Liabilities
116829000
Equity
124549000
Depreciation
2230000
Change In Working Capital
484000
Cash From Operations
-44666000
Capital Expenditures
248000
Cash From Investing
-248000
Cash From Financing
32692000
Net Change In Cash
-12251000
PE
-
PB
22.302557904760373
ROE
-43.23760126536544
ROA
-22.310235398420733
FCF
-44914000
Fcf Percent
-5.903522607781283
Piotroski FScore
1
Health Score
23
Deep Value Investing Score
2.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
7
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
7608000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
7608000
Quarters > 0 > income Statement > operating Expenses
63961000
Quarters > 0 > income Statement > operating Income
-56353000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-53852000
Quarters > 0 > income Statement > net Income
-53852000
Quarters > 0 > income Statement > eps
-0.3210459894385575
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
167739208
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-51622000
Quarters > 0 > income Statement > operating Margin
-740.7071503680337
Quarters > 0 > income Statement > total Other Income Expense Net
2501000
Quarters > 0 > balance Sheet > cash
196218000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
10000000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
215488000
Quarters > 0 > balance Sheet > property Plant Equipment
22072000
Quarters > 0 > balance Sheet > total Assets
241378000
Quarters > 0 > balance Sheet > payables
14490000
Quarters > 0 > balance Sheet > short Term Debt
8394000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
116829000
Quarters > 0 > balance Sheet > equity
124549000
Quarters > 0 > cash Flow > net Income
-53852000
Quarters > 0 > cash Flow > depreciation
2230000
Quarters > 0 > cash Flow > change In Working Capital
484000
Quarters > 0 > cash Flow > cash From Operations
-44666000
Quarters > 0 > cash Flow > capital Expenditures
248000
Quarters > 0 > cash Flow > cash From Investing
-248000
Quarters > 0 > cash Flow > cash From Financing
32692000
Quarters > 0 > cash Flow > net Change In Cash
-12251000
Quarters > 0 > ratios > PE
-0.3210459894385575
Quarters > 0 > ratios > PB
22.302557904760373
Quarters > 0 > ratios > ROE
-43.23760126536544
Quarters > 0 > ratios > ROA
-22.310235398420733
Quarters > 0 > ratios > FCF
-44914000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-5.903522607781283
Quarters > 0 > health Score
23
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
8699000
Quarters > 1 > income Statement > cost Of Revenue
2196000
Quarters > 1 > income Statement > gross Profit
6503000
Quarters > 1 > income Statement > operating Expenses
59262000
Quarters > 1 > income Statement > operating Income
-52759000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-50469000
Quarters > 1 > income Statement > net Income
-50469000
Quarters > 1 > income Statement > eps
-0.30776099954850256
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
163987640
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-50563000
Quarters > 1 > income Statement > operating Margin
-606.4949994252213
Quarters > 1 > income Statement > total Other Income Expense Net
2290000
Quarters > 1 > balance Sheet > cash
208481000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1617000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
223556000
Quarters > 1 > balance Sheet > property Plant Equipment
24287000
Quarters > 1 > balance Sheet > total Assets
252355000
Quarters > 1 > balance Sheet > payables
14664000
Quarters > 1 > balance Sheet > short Term Debt
8136000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
113089000
Quarters > 1 > balance Sheet > equity
139266000
Quarters > 1 > cash Flow > net Income
-50469000
Quarters > 1 > cash Flow > depreciation
2196000
Quarters > 1 > cash Flow > change In Working Capital
-3935000
Quarters > 1 > cash Flow > cash From Operations
-46012000
Quarters > 1 > cash Flow > capital Expenditures
306000
Quarters > 1 > cash Flow > cash From Investing
-306000
Quarters > 1 > cash Flow > cash From Financing
11693000
Quarters > 1 > cash Flow > net Change In Cash
-34582000
Quarters > 1 > ratios > PE
-0.30776099954850256
Quarters > 1 > ratios > PB
19.499628900090475
Quarters > 1 > ratios > ROE
-36.23928309853087
Quarters > 1 > ratios > ROA
-19.999207465673358
Quarters > 1 > ratios > FCF
-46318000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-5.324520059776986
Quarters > 1 > health Score
23
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
9175000
Quarters > 2 > income Statement > cost Of Revenue
2164000
Quarters > 2 > income Statement > gross Profit
7011000
Quarters > 2 > income Statement > operating Expenses
56815000
Quarters > 2 > income Statement > operating Income
-49804000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-46878000
Quarters > 2 > income Statement > net Income
-46878000
Quarters > 2 > income Statement > eps
-0.28843202975977666
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
162527026
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-47640000
Quarters > 2 > income Statement > operating Margin
-542.8228882833787
Quarters > 2 > income Statement > total Other Income Expense Net
2926000
Quarters > 2 > balance Sheet > cash
243075000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1422000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
257976000
Quarters > 2 > balance Sheet > property Plant Equipment
26147000
Quarters > 2 > balance Sheet > total Assets
288343000
Quarters > 2 > balance Sheet > payables
14358000
Quarters > 2 > balance Sheet > short Term Debt
7884000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
116540000
Quarters > 2 > balance Sheet > equity
171803000
Quarters > 2 > cash Flow > net Income
-46878000
Quarters > 2 > cash Flow > depreciation
2164000
Quarters > 2 > cash Flow > change In Working Capital
-23278000
Quarters > 2 > cash Flow > cash From Operations
-63039000
Quarters > 2 > cash Flow > capital Expenditures
165000
Quarters > 2 > cash Flow > cash From Investing
-165000
Quarters > 2 > cash Flow > cash From Financing
4155000
Quarters > 2 > cash Flow > net Change In Cash
-58991000
Quarters > 2 > ratios > PE
-0.28843202975977666
Quarters > 2 > ratios > PB
15.665893788583436
Quarters > 2 > ratios > ROE
-27.285903040109893
Quarters > 2 > ratios > ROA
-16.257720839416944
Quarters > 2 > ratios > FCF
-63204000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-6.888719346049046
Quarters > 2 > health Score
22
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
83748000
Quarters > 3 > income Statement > cost Of Revenue
65732000
Quarters > 3 > income Statement > gross Profit
83748000
Quarters > 3 > income Statement > operating Expenses
60781000
Quarters > 3 > income Statement > operating Income
22967000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
29253000
Quarters > 3 > income Statement > net Income
29253000
Quarters > 3 > income Statement > eps
0.16978895296411853
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
172290361
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
25123000
Quarters > 3 > income Statement > operating Margin
27.42393848211301
Quarters > 3 > income Statement > total Other Income Expense Net
6286000
Quarters > 3 > balance Sheet > cash
302078000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1422000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
320394000
Quarters > 3 > balance Sheet > property Plant Equipment
27998000
Quarters > 3 > balance Sheet > total Assets
352207000
Quarters > 3 > balance Sheet > payables
16262000
Quarters > 3 > balance Sheet > short Term Debt
7638000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
142692000
Quarters > 3 > balance Sheet > equity
209515000
Quarters > 3 > cash Flow > net Income
29253000
Quarters > 3 > cash Flow > depreciation
2156000
Quarters > 3 > cash Flow > change In Working Capital
-78301000
Quarters > 3 > cash Flow > cash From Operations
-43648000
Quarters > 3 > cash Flow > capital Expenditures
86000
Quarters > 3 > cash Flow > cash From Investing
-86000
Quarters > 3 > cash Flow > cash From Financing
34981000
Quarters > 3 > cash Flow > net Change In Cash
-8856000
Quarters > 3 > ratios > PE
0.16978895296411853
Quarters > 3 > ratios > PB
13.617776188626113
Quarters > 3 > ratios > ROE
13.962246139894518
Quarters > 3 > ratios > ROA
8.305627088615502
Quarters > 3 > ratios > FCF
-43734000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.5222094855996561
Quarters > 3 > health Score
56
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
108302000
Annuals > 0 > income Statement > cost Of Revenue
8663000
Annuals > 0 > income Statement > gross Profit
108302000
Annuals > 0 > income Statement > operating Expenses
218705000
Annuals > 0 > income Statement > operating Income
-110403000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-97008000
Annuals > 0 > income Statement > net Income
-97008000
Annuals > 0 > income Statement > eps
-0.7015459669828493
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
138277468
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-101740000
Annuals > 0 > income Statement > operating Margin
-101.93994570737384
Annuals > 0 > income Statement > total Other Income Expense Net
13395000
Annuals > 0 > balance Sheet > cash
302078000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1422000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
320394000
Annuals > 0 > balance Sheet > property Plant Equipment
27998000
Annuals > 0 > balance Sheet > total Assets
352207000
Annuals > 0 > balance Sheet > payables
16262000
Annuals > 0 > balance Sheet > short Term Debt
7638000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
142692000
Annuals > 0 > balance Sheet > equity
209515000
Annuals > 0 > cash Flow > net Income
-97008000
Annuals > 0 > cash Flow > depreciation
8663000
Annuals > 0 > cash Flow > change In Working Capital
-75822000
Annuals > 0 > cash Flow > cash From Operations
-151026000
Annuals > 0 > cash Flow > capital Expenditures
938000
Annuals > 0 > cash Flow > cash From Investing
-938000
Annuals > 0 > cash Flow > cash From Financing
253890000
Annuals > 0 > cash Flow > net Change In Cash
101788000
Annuals > 0 > ratios > PE
-0.7015459669828493
Annuals > 0 > ratios > PB
5.029111548862851
Annuals > 0 > ratios > ROE
-46.301219483091906
Annuals > 0 > ratios > ROA
-27.542893809606284
Annuals > 0 > ratios > FCF
-151964000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1.4031504496685194
Annuals > 0 > health Score
25
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
113305000
Annuals > 1 > income Statement > cost Of Revenue
9206000
Annuals > 1 > income Statement > gross Profit
113305000
Annuals > 1 > income Statement > operating Expenses
181301000
Annuals > 1 > income Statement > operating Income
-67996000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-58190000
Annuals > 1 > income Statement > net Income
-57513000
Annuals > 1 > income Statement > eps
-0.542078048607246
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
106097268
Annuals > 1 > income Statement > income Tax Expense
-677000
Annuals > 1 > income Statement > EBITDA
-58790000
Annuals > 1 > income Statement > operating Margin
-60.01147345659944
Annuals > 1 > income Statement > total Other Income Expense Net
9806000
Annuals > 1 > balance Sheet > cash
200351000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
21086000
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
235373000
Annuals > 1 > balance Sheet > property Plant Equipment
35721000
Annuals > 1 > balance Sheet > total Assets
274949000
Annuals > 1 > balance Sheet > payables
12839000
Annuals > 1 > balance Sheet > short Term Debt
6714000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
235319000
Annuals > 1 > balance Sheet > equity
39630000
Annuals > 1 > cash Flow > net Income
-57513000
Annuals > 1 > cash Flow > depreciation
9206000
Annuals > 1 > cash Flow > change In Working Capital
19081000
Annuals > 1 > cash Flow > cash From Operations
-19431000
Annuals > 1 > cash Flow > capital Expenditures
1115000
Annuals > 1 > cash Flow > cash From Investing
-1115000
Annuals > 1 > cash Flow > cash From Financing
132534000
Annuals > 1 > cash Flow > net Change In Cash
111893000
Annuals > 1 > ratios > PE
-0.542078048607246
Annuals > 1 > ratios > PB
20.400231697199093
Annuals > 1 > ratios > ROE
-145.12490537471612
Annuals > 1 > ratios > ROA
-20.917697463893305
Annuals > 1 > ratios > FCF
-20546000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.18133356868628922
Annuals > 1 > health Score
8
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
3649000
Annuals > 2 > income Statement > cost Of Revenue
10114000
Annuals > 2 > income Statement > gross Profit
3649000
Annuals > 2 > income Statement > operating Expenses
166369000
Annuals > 2 > income Statement > operating Income
-162720000
Annuals > 2 > income Statement > interest Expense
1578000
Annuals > 2 > income Statement > pretax Income
-161142000
Annuals > 2 > income Statement > net Income
-161823000
Annuals > 2 > income Statement > eps
-2.0521379464620297
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
78855810
Annuals > 2 > income Statement > income Tax Expense
681000
Annuals > 2 > income Statement > EBITDA
-152606000
Annuals > 2 > income Statement > operating Margin
-4459.303918881886
Annuals > 2 > income Statement > total Other Income Expense Net
1578000
Annuals > 2 > balance Sheet > cash
88497000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
0
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
98537000
Annuals > 2 > balance Sheet > property Plant Equipment
44127000
Annuals > 2 > balance Sheet > total Assets
146386000
Annuals > 2 > balance Sheet > payables
16915000
Annuals > 2 > balance Sheet > short Term Debt
5496000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
191477000
Annuals > 2 > balance Sheet > equity
-45091000
Annuals > 2 > cash Flow > net Income
-161823000
Annuals > 2 > cash Flow > depreciation
10114000
Annuals > 2 > cash Flow > change In Working Capital
6722000
Annuals > 2 > cash Flow > cash From Operations
-127781000
Annuals > 2 > cash Flow > capital Expenditures
1361000
Annuals > 2 > cash Flow > cash From Investing
-1255000
Annuals > 2 > cash Flow > cash From Financing
67188000
Annuals > 2 > cash Flow > net Change In Cash
-62058000
Annuals > 2 > ratios > PE
-2.0521379464620297
Annuals > 2 > ratios > PB
-13.325969089175224
Annuals > 2 > ratios > ROE
358.88092967554496
Annuals > 2 > ratios > ROA
-110.54540734769718
Annuals > 2 > ratios > FCF
-129142000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-35.39106604549192
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
40964000
Annuals > 3 > income Statement > cost Of Revenue
121875000
Annuals > 3 > income Statement > gross Profit
40964000
Annuals > 3 > income Statement > operating Expenses
167980000
Annuals > 3 > income Statement > operating Income
-127016000
Annuals > 3 > income Statement > interest Expense
14432000
Annuals > 3 > income Statement > pretax Income
-122449000
Annuals > 3 > income Statement > net Income
-122245000
Annuals > 3 > income Statement > eps
-2.358777905098036
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
51825566
Annuals > 3 > income Statement > income Tax Expense
-204000
Annuals > 3 > income Statement > EBITDA
-117181000
Annuals > 3 > income Statement > operating Margin
-310.0673762327898
Annuals > 3 > income Statement > total Other Income Expense Net
4567000
Annuals > 3 > balance Sheet > cash
150564000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
0
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
162564000
Annuals > 3 > balance Sheet > property Plant Equipment
40644000
Annuals > 3 > balance Sheet > total Assets
207007000
Annuals > 3 > balance Sheet > payables
7281000
Annuals > 3 > balance Sheet > short Term Debt
4961000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
174509000
Annuals > 3 > balance Sheet > equity
32498000
Annuals > 3 > cash Flow > net Income
-122245000
Annuals > 3 > cash Flow > depreciation
9835000
Annuals > 3 > cash Flow > change In Working Capital
7010000
Annuals > 3 > cash Flow > cash From Operations
-88993000
Annuals > 3 > cash Flow > capital Expenditures
560000
Annuals > 3 > cash Flow > cash From Investing
-560000
Annuals > 3 > cash Flow > cash From Financing
55828000
Annuals > 3 > cash Flow > net Change In Cash
-33933000
Annuals > 3 > ratios > PE
-2.358777905098036
Annuals > 3 > ratios > PB
12.151849742137976
Annuals > 3 > ratios > ROE
-376.1616099452274
Annuals > 3 > ratios > ROA
-59.05355857531388
Annuals > 3 > ratios > FCF
-89553000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-2.186139048921004
Annuals > 3 > health Score
9
Valuation > metrics > PE
-0.3210459894385575
Valuation > metrics > PB
22.302557904760373
Valuation > final Score
20
Valuation > verdict
643.4% Overvalued
Profitability > metrics > ROE
-43.23760126536544
Profitability > metrics > ROA
-24.99071874071874
Profitability > metrics > Net Margin
-7.078338590956887
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.9380163630378405
Risk > metrics > Interest Coverage
-25.270403587443948
Risk > final Score
-53
Risk > verdict
High
Liquidity > metrics > Current Ratio
9.416535570704422
Liquidity > metrics > Quick Ratio
9.416535570704422
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
40
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
85
Prev Risks > 0
-2197
Prev Risks > 1
-213
Prev Risks > 2
70
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:37:42.976Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.32
Earnings History > 0 > eps Estimate
-0.2547
Earnings History > 0 > eps Difference
-0.0653
Earnings History > 0 > surprise Percent
-25.638
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.31
Earnings History > 1 > eps Estimate
-0.27
Earnings History > 1 > eps Difference
-0.04
Earnings History > 1 > surprise Percent
-14.8148
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.29
Earnings History > 2 > eps Estimate
-0.2556
Earnings History > 2 > eps Difference
-0.0344
Earnings History > 2 > surprise Percent
-13.4585
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-04
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.17
Earnings History > 3 > eps Estimate
-0.17
Earnings History > 3 > eps Difference
0.34
Earnings History > 3 > surprise Percent
200
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.466
Earnings History > 4 > eps Estimate
-0.28
Earnings History > 4 > eps Difference
-0.186
Earnings History > 4 > surprise Percent
-66.4286
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.25
Earnings History > 5 > eps Estimate
-0.21
Earnings History > 5 > eps Difference
-0.04
Earnings History > 5 > surprise Percent
-19.0476
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.24
Earnings History > 6 > eps Estimate
-0.21
Earnings History > 6 > eps Difference
-0.03
Earnings History > 6 > surprise Percent
-14.2857
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-06
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.15
Earnings History > 7 > eps Estimate
-0.23
Earnings History > 7 > eps Difference
0.08
Earnings History > 7 > surprise Percent
34.7826
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.07
Earnings History > 8 > eps Estimate
-0.18
Earnings History > 8 > eps Difference
0.25
Earnings History > 8 > surprise Percent
138.8889
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-03
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.2
Earnings History > 9 > eps Estimate
-0.33
Earnings History > 9 > eps Difference
0.13
Earnings History > 9 > surprise Percent
39.3939
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-03
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.27
Earnings History > 10 > eps Estimate
-0.04
Earnings History > 10 > eps Difference
-0.23
Earnings History > 10 > surprise Percent
-575
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-22
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.47
Earnings History > 11 > eps Estimate
-0.41
Earnings History > 11 > eps Difference
-0.06
Earnings History > 11 > surprise Percent
-14.6341
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.42
Earnings History > 12 > eps Estimate
-0.5
Earnings History > 12 > eps Difference
0.08
Earnings History > 12 > surprise Percent
16
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.62
Earnings History > 13 > eps Estimate
-0.54
Earnings History > 13 > eps Difference
-0.08
Earnings History > 13 > surprise Percent
-14.8148
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.62
Earnings History > 14 > eps Estimate
-0.56
Earnings History > 14 > eps Difference
-0.06
Earnings History > 14 > surprise Percent
-10.7143
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-03
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.61
Earnings History > 15 > eps Estimate
-0.51
Earnings History > 15 > eps Difference
-0.1
Earnings History > 15 > surprise Percent
-19.6078
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.12
Earnings History > 16 > eps Estimate
-0.63
Earnings History > 16 > eps Difference
0.51
Earnings History > 16 > surprise Percent
80.9524
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-05
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.78
Earnings History > 17 > eps Estimate
-0.64
Earnings History > 17 > eps Difference
-0.14
Earnings History > 17 > surprise Percent
-21.875
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.86
Earnings History > 18 > eps Estimate
-0.59
Earnings History > 18 > eps Difference
-0.27
Earnings History > 18 > surprise Percent
-45.7627
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-04
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.59
Earnings History > 19 > eps Estimate
-0.61
Earnings History > 19 > eps Difference
0.02
Earnings History > 19 > surprise Percent
3.2787
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-09
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.86
Earnings History > 20 > eps Estimate
-0.69
Earnings History > 20 > eps Difference
-0.17
Earnings History > 20 > surprise Percent
-24.6377
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-10
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-1.15
Earnings History > 21 > eps Estimate
-0.97
Earnings History > 21 > eps Difference
-0.18
Earnings History > 21 > surprise Percent
-18.5567
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-11
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-1.38
Earnings History > 22 > eps Estimate
-1.2
Earnings History > 22 > eps Difference
-0.18
Earnings History > 22 > surprise Percent
-15
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-02
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-1.65
Earnings History > 23 > eps Estimate
-1.43
Earnings History > 23 > eps Difference
-0.22
Earnings History > 23 > surprise Percent
-15.3846
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-05
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-1.48
Earnings History > 24 > eps Estimate
-1.34
Earnings History > 24 > eps Difference
-0.14
Earnings History > 24 > surprise Percent
-10.4478
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-07-29
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-1.22
Earnings History > 25 > eps Estimate
-1.11
Earnings History > 25 > eps Difference
-0.11
Earnings History > 25 > surprise Percent
-9.9099
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-10
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-1.36
Earnings History > 26 > eps Estimate
-1.13
Earnings History > 26 > eps Difference
-0.23
Earnings History > 26 > surprise Percent
-20.354
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-01
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-1.28
Earnings History > 27 > eps Estimate
-1.15
Earnings History > 27 > eps Difference
-0.13
Earnings History > 27 > surprise Percent
-11.3043
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-09
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-1.28
Earnings History > 28 > eps Estimate
-1.2
Earnings History > 28 > eps Difference
-0.08
Earnings History > 28 > surprise Percent
-6.6667
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-09
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-1.23
Earnings History > 29 > eps Estimate
-0.55
Earnings History > 29 > eps Difference
-0.68
Earnings History > 29 > surprise Percent
-123.6364
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-09
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-1.26
Earnings History > 30 > eps Estimate
-0.84
Earnings History > 30 > eps Difference
-0.42
Earnings History > 30 > surprise Percent
-50
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-12
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
BeforeMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-1.1
Earnings History > 31 > eps Estimate
-1
Earnings History > 31 > eps Difference
-0.1
Earnings History > 31 > surprise Percent
-10
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-11-09
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
BeforeMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.94
Earnings History > 32 > eps Estimate
-0.94
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
0
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-08-09
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
BeforeMarket
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.92
Earnings History > 33 > eps Estimate
-0.79
Earnings History > 33 > eps Difference
-0.13
Earnings History > 33 > surprise Percent
-16.4557
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-05-10
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
BeforeMarket
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.89
Earnings History > 34 > eps Estimate
-0.77
Earnings History > 34 > eps Difference
-0.12
Earnings History > 34 > surprise Percent
-15.5844
Earnings History > 35 > period
2016-12-31
Earnings History > 35 > report Date
2017-03-16
Earnings History > 35 > date
2016-12-31
Earnings History > 35 > before After Market
BeforeMarket
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.79
Earnings History > 35 > eps Estimate
-0.75
Earnings History > 35 > eps Difference
-0.04
Earnings History > 35 > surprise Percent
-5.3333
Earnings History > 36 > period
2016-09-30
Earnings History > 36 > report Date
2016-11-09
Earnings History > 36 > date
2016-09-30
Earnings History > 36 > before After Market
AfterMarket
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.75
Earnings History > 36 > eps Estimate
-0.54
Earnings History > 36 > eps Difference
-0.21
Earnings History > 36 > surprise Percent
-38.8889
Earnings History > 37 > period
2016-06-30
Earnings History > 37 > report Date
2016-08-15
Earnings History > 37 > date
2016-06-30
Earnings History > 37 > before After Market
AfterMarket
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-0.51
Earnings History > 37 > eps Estimate
-0.37
Earnings History > 37 > eps Difference
-0.14
Earnings History > 37 > surprise Percent
-37.8378
Earnings History > 38 > period
2016-03-31
Earnings History > 38 > report Date
2016-05-16
Earnings History > 38 > date
2016-03-31
Earnings History > 38 > before After Market
AfterMarket
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-0.36
Earnings History > 38 > eps Estimate
-0.39
Earnings History > 38 > eps Difference
0.03
Earnings History > 38 > surprise Percent
7.6923
Earnings History > 39 > period
2015-12-31
Earnings History > 39 > report Date
2016-03-30
Earnings History > 39 > date
2015-12-31
Earnings History > 39 > before After Market
BeforeMarket
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-0.47
Earnings History > 39 > eps Estimate
-0.28
Earnings History > 39 > eps Difference
-0.19
Earnings History > 39 > surprise Percent
-67.8571
Earnings History > 40 > period
2015-09-30
Earnings History > 40 > report Date
2015-12-17
Earnings History > 40 > date
2015-09-30
Earnings History > 40 > before After Market
BeforeMarket
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
-0.54
Earnings History > 40 > eps Estimate
-0.29
Earnings History > 40 > eps Difference
-0.25
Earnings History > 40 > surprise Percent
-86.2069
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, an RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-N531, an exon skipping oligonucleotide for the treatment of Duchenne muscular dystrophy; and WVE-003, an allele-selective oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$19.8
Analyst Picks
Strong Buy
9
Buy
3
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 86.98% of the total shares of Wave Life Sciences Ltd
1.
RA Capital Management, LLC(11.4315%)
since
2025/06/30
2.
Adage Capital Partners Gp LLC(9.4309%)
since
2025/06/30
3.
BlackRock Inc(6.5213%)
since
2025/06/30
4.
Maverick Capital Ltd(5.1886%)
since
2025/06/30
5.
Driehaus Capital Management LLC(4.102%)
since
2025/06/30
6.
M28 Capital Management LP(3.5575%)
since
2025/06/30
7.
T. Rowe Price Associates, Inc.(3.2597%)
since
2025/06/30
8.
Kynam Capital Management, LP(2.8639%)
since
2025/06/30
9.
683 Capital Management LLC(2.5749%)
since
2025/06/30
10.
Bellevue Group AG(2.5715%)
since
2025/06/30
11.
BB Biotech AG Ord(2.5715%)
since
2024/12/31
12.
Siren, L.L.C.(2.3214%)
since
2025/06/30
13.
Vanguard Group Inc(2.1837%)
since
2025/06/30
14.
Loomis, Sayles & Company LP(2.0698%)
since
2025/06/30
15.
Emerald Advisers, LLC(2.0456%)
since
2025/06/30
16.
Geode Capital Management, LLC(1.733%)
since
2025/06/30
17.
State Street Corp(1.7313%)
since
2025/06/30
18.
iShares Russell 2000 ETF(1.6963%)
since
2025/08/31
19.
PRIMECAP Management Company(1.5486%)
since
2025/06/30
20.
PRIMECAP Odyssey Aggressive Growth(1.5031%)
since
2025/06/30
21.
Artisan Partners Limited Partnership(1.4224%)
since
2025/06/30
22.
US Small-Cap Growth II Equity Comp(1.3362%)
since
2025/06/30
23.
T. Rowe Price New Horizons(1.3339%)
since
2025/07/31
24.
Affinity Asset Advisors, LLC(1.2563%)
since
2025/06/30
25.
Emerald Mutual Fund Advisers Trust(1.2168%)
since
2025/06/30
26.
Loomis Sayles Small Cap Growth Instl(1.138%)
since
2025/07/31
27.
Artisan Non-U.S. Small-Mid Growth Comp(0.9511%)
since
2025/06/30
28.
Artisan International Small-Mid Investor(0.9511%)
since
2025/06/30
29.
Vanguard Institutional Extnd Mkt Idx Tr(0.8062%)
since
2025/07/31
30.
Fidelity Small Cap Index(0.7065%)
since
2025/06/30
31.
T. Rowe Price Health Sciences(0.669%)
since
2025/07/31
32.
Polar Capital Biotech S Inc(0.628%)
since
2025/07/31
33.
Emerald Growth A(0.6047%)
since
2025/07/31
34.
iShares Russell 2000 Growth ETF(0.5521%)
since
2025/08/31
35.
iShares Biotechnology ETF(0.4627%)
since
2025/08/31
36.
Principal SmallCap Growth I Instl(0.4408%)
since
2025/07/31
37.
Heptagon Driehaus US Micro Cap Eq C$ Acc(0.4096%)
since
2025/07/31
38.
Fidelity Extended Market Index(0.4044%)
since
2025/07/31
39.
T. Rowe Price New Horizons Tr-A(0.3915%)
since
2025/06/30
40.
Driehaus Small Cap Growth Institutional(0.3908%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.32
EPS Estimate
-0.2547
EPS Difference
-0.0653
Surprise Percent
-25.638%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.